These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29476738)

  • 1. Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase.
    Lunev S; Bosch SS; Batista FA; Wang C; Li J; Linzke M; Kruithof P; Chamoun G; Dömling ASS; Wrenger C; Groves MR
    Biochem Biophys Res Commun; 2018 Mar; 497(3):835-842. PubMed ID: 29476738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of truncated aspartate transcarbamoylase from Plasmodium falciparum.
    Lunev S; Bosch SS; Batista Fde A; Wrenger C; Groves MR
    Acta Crystallogr F Struct Biol Commun; 2016 Jul; 72(Pt 7):523-33. PubMed ID: 27380369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Highlight in Malarial Drug Discovery: Aspartate Transcarbamoylase.
    Wang C; Krüger A; Du X; Wrenger C; Groves MR
    Front Cell Infect Microbiol; 2022; 12():841833. PubMed ID: 35310840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New regulatory mechanism-based inhibitors of aspartate transcarbamoylase for potential anticancer drug development.
    Lei Z; Wang B; Lu Z; Wang N; Tan H; Zheng J; Jia Z
    FEBS J; 2020 Aug; 287(16):3579-3599. PubMed ID: 31967710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-state inhibitors of E. coli aspartate transcarbamoylase that prevent the allosteric transition.
    Heng S; Stieglitz KA; Eldo J; Xia J; Cardia JP; Kantrowitz ER
    Biochemistry; 2006 Aug; 45(33):10062-71. PubMed ID: 16906764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Target Validation of Aspartate Transcarbamoylase from
    Bosch SS; Lunev S; Batista FA; Linzke M; Kronenberger T; Dömling ASS; Groves MR; Wrenger C
    ACS Infect Dis; 2020 May; 6(5):986-999. PubMed ID: 32129597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-Molecule Allosteric Inhibitors of Human Aspartate Transcarbamoylase Suppress Proliferation of Bone Osteosarcoma Epithelial Cells.
    Wang C; Zhang B; Cong Y; Du X; Chen S; Visser L; Ruiz-Moreno AJ; Zhang L; Reggiori F; Dömling ASS; Groves MR
    ChemMedChem; 2024 Jul; 19(13):e202300688. PubMed ID: 38602859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.
    Diaz CA; Allocco J; Powles MA; Yeung L; Donald RG; Anderson JW; Liberator PA
    Mol Biochem Parasitol; 2006 Mar; 146(1):78-88. PubMed ID: 16325279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the Pathway and Dynamics of Bestatin Inhibition of the Plasmodium falciparum M1 Aminopeptidase PfA-M1.
    Yang W; Riley BT; Lei X; Porebski BT; Kass I; Buckle AM; McGowan S
    ChemMedChem; 2018 Dec; 13(23):2504-2513. PubMed ID: 30318749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of feedback inhibition and sequential firing of active sites in plant aspartate transcarbamoylase.
    Bellin L; Del Caño-Ochoa F; Velázquez-Campoy A; Möhlmann T; Ramón-Maiques S
    Nat Commun; 2021 Feb; 12(1):947. PubMed ID: 33574254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo lead optimization of triazine derivatives identifies potent antimalarials.
    Shandilya A; Hoda N; Khan S; Jameel E; Kumar J; Jayaram B
    J Mol Graph Model; 2017 Jan; 71():96-103. PubMed ID: 27880887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibition of the aspartate aminotransferase of Plasmodium falciparum.
    Wrenger C; Müller IB; Schifferdecker AJ; Jain R; Jordanova R; Groves MR
    J Mol Biol; 2011 Jan; 405(4):956-71. PubMed ID: 21087616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and Functional Characterization of Human Aspartate Transcarbamoylase, the Target of the Anti-tumoral Drug PALA.
    Ruiz-Ramos A; Velázquez-Campoy A; Grande-García A; Moreno-Morcillo M; Ramón-Maiques S
    Structure; 2016 Jul; 24(7):1081-94. PubMed ID: 27265852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
    Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I
    PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Small-Molecule Allosteric Inhibitors of
    Wang C; Zhang B; Krüger A; Du X; Visser L; Dömling ASS; Wrenger C; Groves MR
    J Am Chem Soc; 2022 Oct; 144(41):19070-19077. PubMed ID: 36195578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal ion involvement in the allosteric mechanism of Escherichia coli aspartate transcarbamoylase.
    Cockrell GM; Kantrowitz ER
    Biochemistry; 2012 Sep; 51(36):7128-37. PubMed ID: 22906065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the mechanisms of catalysis and heterotropic regulation of Escherichia coli aspartate transcarbamoylase based upon a structure of the enzyme complexed with the bisubstrate analogue N-phosphonacetyl-L-aspartate at 2.1 A.
    Jin L; Stec B; Lipscomb WN; Kantrowitz ER
    Proteins; 1999 Dec; 37(4):729-42. PubMed ID: 10651286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of α-Thymidine Inhibitors with Thymidylate Kinase from Plasmodium falciparum.
    Chen MD; Sinha K; Rule GS; Ly DH
    Biochemistry; 2018 May; 57(19):2868-2875. PubMed ID: 29684273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the structural features of Aspartate Trans Carbamoylase (TtATCase) from Thermus thermophilus HB8 through in silico approaches: a potential drug target for inborn error of pyrimidine metabolism.
    Kanagarajan S; Mutharasappan N; Dhamodharan P; Jeyaraman M; Ramadas K; Jeyaraman J
    J Biomol Struct Dyn; 2014 Apr; 32(4):591-601. PubMed ID: 23663010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico identification of novel inhibitors against Plasmodium falciparum dihydroorate dehydrogenase.
    Wadood A; Ulhaq ZU
    J Mol Graph Model; 2013 Mar; 40():40-7. PubMed ID: 23353582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.